X

Trial Profile

Prospective Comparison of ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 18 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sacubitril/valsartan (Primary)
Indications Heart failure; Right ventricular dysfunction
Focus Therapeutic Use
Acronyms PARACYS-RV

Most Recent Events

11 Mar 2024 Status changed from active, no longer recruiting to discontinued. (The trial was prematurely terminated due to safety concerns.)
21 Dec 2022 Status changed from recruiting to active, no longer recruiting.
04 Apr 2022 Planned End Date changed from 12 Nov 2024 to 12 Mar 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com